Cargando…

Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study

Measurement of both calprotectin and lactoferrin in faeces has successfully been used to discriminate between functional and inflammatory bowel conditions, but evidence is limited for Clostridium difficile infection (CDI). We prospectively recruited a cohort of 164 CDI cases and 52 controls with ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swale, Andrew, Miyajima, Fabio, Roberts, Paul, Hall, Amanda, Little, Margaret, Beadsworth, Mike B. J., Beeching, Nick J., Kolamunnage-Dona, Ruwanthi, Parry, Chris M., Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149523/ https://www.ncbi.nlm.nih.gov/pubmed/25170963 http://dx.doi.org/10.1371/journal.pone.0106118

Ejemplares similares

Serum Mannose-Binding Lectin Concentration, but Not Genotype, Is Associated With Clostridium difficile Infection Recurrence: A Prospective Cohort Study
por: Swale, Andrew, et al.
Publicado: (2014)

Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom
por: Miyajima, Fabio, et al.
Publicado: (2011)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008)

Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence
por: Kumar, Nitin, et al.
Publicado: (2016)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

2365. Volatile Metabolite-Based Detection of Clostridium difficile Infection (CDI)
por: Aloum, Obadah, et al.
Publicado: (2019)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Faecal volatile biomarkers of Clostridium difficile infection
por: Patel, Mitesh, et al.
Publicado: (2019)

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis
por: Bohra, Anuj, et al.
Publicado: (2023)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

The role of Clostridium difficile in the paediatric and neonatal gut — a narrative review
por: Lees, E. A., et al.
Publicado: (2016)

Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
por: Chilton, C. H., et al.
Publicado: (2016)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016)

527 Age-Related Changes in the Incidence of Community-Associated Clostridium Difficile Infection (CDI)
por: Faden, Howard
Publicado: (2014)

485. On- and Post-Antibiotic Effects on the Risk of Hospital-Acquired Clostridium difficile Infection (CDI)
por: Stevens, Vanessa, et al.
Publicado: (2018)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS)
por: Dorr, Mary Beth, et al.
Publicado: (2017)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

467. Investigation of a Clostridium difficile Infection (CDI) Outbreak in a Community Teaching Hospital
por: Parker, Laura, et al.
Publicado: (2018)

Faecal Microbiota Transplantation for Clostridium Difficile – a local perspective
por: Diamond, C, et al.
Publicado: (2017)

Faecal transplantation for the treatment of Clostridium difficile infection in a marmoset
por: Yamazaki, Yumiko, et al.
Publicado: (2017)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

Are Patients with Prior Clostridium difficile Infection (CDI) a Potential Source of Transmission during Hospital Admissions?
por: Gonzalez-Orta, Melany, et al.
Publicado: (2017)

Predictors of 30-day All-cause Mortality in Veterans with First Recurrence of Clostridium difficile Infection (CDI)
por: Morrill, Haley, et al.
Publicado: (2017)

1980. Efficacy of an Oral Vancomycin Loading Dose (LD) in the Treatment of Confirmed Clostridium Difficile Infection (CDI)
por: Tirmizi, Samad, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

Clostridium difficile Infection–Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds
por: Talbot, George H., et al.
Publicado: (2019)

A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC)
por: Owens, Lynn, et al.
Publicado: (2011)

Oral Cavity Calprotectin and Lactoferrin Levels in Relation to Radiotherapy
por: Keskin, Mutlu, et al.
Publicado: (2022)

Clostridium difficile isolated from faecal samples in patients with ulcerative colitis
por: Shoaei, Parisa, et al.
Publicado: (2019)

Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI
por: Navalkele, Bhagyashri D., et al.
Publicado: (2016)

P028: Examining the relationship between fluoroquinolone use and Clostridium difficile infections (CDI): a meta-analysis
por: Formanek, MB, et al.
Publicado: (2013)

Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study
por: Stevens, Vanessa W., et al.
Publicado: (2016)

Declining Rates of Clostridium difficile infections (CDI) in Veterans Affairs (VA) Long-term Care Facilities (LTCF)
por: Evans, Martin, et al.
Publicado: (2017)

470. Concomitant Antibiotic Use and Death Among a National Cohort of Veterans With Clostridium difficile Infection (CDI)
por: Appaneal, Haley, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gme4mbdm91vr5fn4t7fr5klifp